Pain in osteoarthritis from a symptom to a disease

S Perrot, T Anne-Priscille - Best Practice & Research Clinical Rheumatology, 2023 - Elsevier
Pain is the most frequent symptom of osteoarthritis (OA), occurring much more commonly
than stiffness or disability. Classically, OA-related pain has been considered to be a …

STING mediates experimental osteoarthritis and mechanical allodynia in mouse

Y Shin, D Cho, SK Kim, JS Chun - Arthritis Research & Therapy, 2023 - Springer
Background This study was performed to develop therapeutic targets of osteoarthritis (OA)
that can be targeted to alleviate OA development (ie, cartilage destruction) and relieve the …

Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior

H Li, X Ding, R Terkeltaub, H Lin, Y Zhang… - Arthritis Research & …, 2020 - Springer
Background Metformin could activate adenosine monophosphate-activated protein kinase
(AMPK) which was postulated as a potential therapeutic target for osteoarthritis. This study …

Hyaluronan modulates TRPV1 channel opening, reducing peripheral nociceptor activity and pain

R Caires, E Luis, FJ Taberner… - Nature …, 2015 - nature.com
Hyaluronan (HA) is present in the extracellular matrix of all body tissues, including synovial
fluid in joints, in which it behaves as a filter that buffers transmission of mechanical forces to …

[HTML][HTML] Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia

RP Hulse, N Beazley-Long, J Hua, H Kennedy… - Neurobiology of …, 2014 - Elsevier
Vascular endothelial growth factor-A (VEGF-A) is best known as a key regulator of the
formation of new blood vessels. Neutralization of VEGF-A with anti-VEGF therapy eg …

[HTML][HTML] The challenges of treating osteoarthritis pain and opportunities for novel peripherally directed therapeutic strategies

S Gonçalves, PRW Gowler, SG Woodhams… - …, 2022 - Elsevier
Osteoarthritis (OA) is a chronic joint disease that represents an increasingly substantial
global burden. Joint pain is the most significant symptom of OA. Unfortunately, current …

Modulators of transient receptor potential (TRP) channels as therapeutic options in lung disease

A Dietrich - Pharmaceuticals, 2019 - mdpi.com
The lungs are essential for gas exchange and serve as the gateways of our body to the
external environment. They are easily accessible for drugs from both sides, the airways and …

Transient receptor potential vanilloid 1: A potential therapeutic target for the treatment of osteoarthritis and rheumatoid arthritis

Z Liao, M Umar, X Huang, L Qin, G Xiao… - Cell …, 2024 - Wiley Online Library
This study aims to determine the molecular mechanisms and analgesic effects of transient
receptor potential vanilloid 1 (TRPV1) in the treatments of osteoarthritis (OA) and rheumatoid …

Injectable capsaicin for the management of pain due to osteoarthritis

JN Campbell, R Stevens, P Hanson, J Connolly… - Molecules, 2021 - mdpi.com
Capsaicin is a potent agonist of the TRPV1 channel, a transduction channel that is highly
expressed in nociceptive fibers (pain fibers) throughout the peripheral nervous system …

Bioactives and their roles in bone metabolism of osteoarthritis: evidence and mechanisms on gut-bone axis

S Basak, KSN Hridayanka, AK Duttaroy - Frontiers in Immunology, 2024 - frontiersin.org
Bioactives significantly modify and maintain human health. Available data suggest that
Bioactives might play a beneficial role in chronic inflammatory diseases. Although promised …